• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的 G 蛋白偶联受体(GPCRs)及其配体的化学基因组学分析:一种潜在的受体去孤儿化策略。

A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.

机构信息

Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Leiden University, 2333CC, The Netherlands.

出版信息

BMC Bioinformatics. 2010 Jun 10;11:316. doi: 10.1186/1471-2105-11-316.

DOI:10.1186/1471-2105-11-316
PMID:20537162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2897831/
Abstract

BACKGROUND

G protein-coupled receptors (GPCRs) represent a family of well-characterized drug targets with significant therapeutic value. Phylogenetic classifications may help to understand the characteristics of individual GPCRs and their subtypes. Previous phylogenetic classifications were all based on the sequences of receptors, adding only minor information about the ligand binding properties of the receptors. In this work, we compare a sequence-based classification of receptors to a ligand-based classification of the same group of receptors, and evaluate the potential to use sequence relatedness as a predictor for ligand interactions thus aiding the quest for ligands of orphan receptors.

RESULTS

We present a classification of GPCRs that is purely based on their ligands, complementing sequence-based phylogenetic classifications of these receptors. Targets were hierarchically classified into phylogenetic trees, for both sequence space and ligand (substructure) space. The overall organization of the sequence-based tree and substructure-based tree was similar; in particular, the adenosine receptors cluster together as well as most peptide receptor subtypes (e.g. opioid, somatostatin) and adrenoceptor subtypes. In ligand space, the prostanoid and cannabinoid receptors are more distant from the other targets, whereas the tachykinin receptors, the oxytocin receptor, and serotonin receptors are closer to the other targets, which is indicative for ligand promiscuity. In 93% of the receptors studied, de-orphanization of a simulated orphan receptor using the ligands of related receptors performed better than random (AUC > 0.5) and for 35% of receptors de-orphanization performance was good (AUC > 0.7).

CONCLUSIONS

We constructed a phylogenetic classification of GPCRs that is solely based on the ligands of these receptors. The similarities and differences with traditional sequence-based classifications were investigated: our ligand-based classification uncovers relationships among GPCRs that are not apparent from the sequence-based classification. This will shed light on potential cross-reactivity of GPCR ligands and will aid the design of new ligands with the desired activity profiles. In addition, we linked the ligand-based classification with a ligand-focused sequence-based classification described in literature and proved the potential of this method for de-orphanization of GPCRs.

摘要

背景

G 蛋白偶联受体(GPCR)是一组经过充分研究的药物靶点,具有重要的治疗价值。系统发生分类有助于了解单个 GPCR 及其亚型的特征。以前的系统发生分类都是基于受体序列,仅添加了有关受体配体结合特性的少量信息。在这项工作中,我们将受体的序列分类与同一组受体的基于配体的分类进行了比较,并评估了将序列相关性用作预测配体相互作用的可能性,从而有助于寻找孤儿受体的配体。

结果

我们提出了一种完全基于配体的 GPCR 分类方法,补充了这些受体的基于序列的系统发生分类。将目标分为基于序列的树和基于配体(亚结构)的树的层次结构。基于序列的树和基于亚结构的树的整体组织相似;特别是,腺苷受体以及大多数肽受体亚型(例如阿片样物质、生长抑素)和肾上腺素受体亚型聚集在一起。在配体空间中,前列腺素和大麻素受体与其他靶标相距较远,而速激肽受体、催产素受体和 5-羟色胺受体与其他靶标较近,这表明配体的混杂性。在所研究的 93%的受体中,使用相关受体的配体对模拟孤儿受体进行去孤儿化的效果优于随机(AUC>0.5),并且对于 35%的受体,去孤儿化性能良好(AUC>0.7)。

结论

我们构建了一种完全基于这些受体配体的 GPCR 系统发生分类。研究了与传统基于序列的分类的相似性和差异:我们的基于配体的分类揭示了基于序列的分类中不明显的 GPCR 之间的关系。这将揭示 GPCR 配体的潜在交叉反应性,并有助于设计具有所需活性谱的新型配体。此外,我们将基于配体的分类与文献中描述的基于配体的序列分类联系起来,并证明了该方法对 GPCR 去孤儿化的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/e492253877ab/1471-2105-11-316-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/0736da9bd335/1471-2105-11-316-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/f05b566b8d02/1471-2105-11-316-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/619d3516f389/1471-2105-11-316-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/e492253877ab/1471-2105-11-316-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/0736da9bd335/1471-2105-11-316-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/f05b566b8d02/1471-2105-11-316-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/619d3516f389/1471-2105-11-316-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/2897831/e492253877ab/1471-2105-11-316-4.jpg

相似文献

1
A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.一种新的 G 蛋白偶联受体(GPCRs)及其配体的化学基因组学分析:一种潜在的受体去孤儿化策略。
BMC Bioinformatics. 2010 Jun 10;11:316. doi: 10.1186/1471-2105-11-316.
2
A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.胺能 G 蛋白偶联受体的结构化学生物基因组学分析:组胺受体配体设计的启示。
Br J Pharmacol. 2013 Sep;170(1):101-26. doi: 10.1111/bph.12248.
3
A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors.人G蛋白偶联受体跨膜结合腔的化学基因组学分析
Proteins. 2006 Feb 1;62(2):509-38. doi: 10.1002/prot.20768.
4
A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?G蛋白偶联受体化学基因组学的结构框架:残基编号蕴含着什么信息?
Methods Mol Biol. 2018;1705:73-113. doi: 10.1007/978-1-4939-7465-8_4.
5
A pharmacological organization of G protein-coupled receptors.G 蛋白偶联受体的药理学组织。
Nat Methods. 2013 Feb;10(2):140-6. doi: 10.1038/nmeth.2324. Epub 2013 Jan 6.
6
Classification of GPCRs using family specific motifs.基于家族特异性基序对 G 蛋白偶联受体进行分类。
IEEE/ACM Trans Comput Biol Bioinform. 2011 Nov-Dec;8(6):1495-508. doi: 10.1109/TCBB.2010.101.
7
Virtual screening of GPCRs: an in silico chemogenomics approach.G蛋白偶联受体的虚拟筛选:一种计算机辅助化学基因组学方法。
BMC Bioinformatics. 2008 Sep 6;9:363. doi: 10.1186/1471-2105-9-363.
8
Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis.视紫红质样G蛋白偶联受体的序列、结构和配体结合进化:基于晶体结构的系统发育分析
PLoS One. 2015 Apr 16;10(4):e0123533. doi: 10.1371/journal.pone.0123533. eCollection 2015.
9
GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.GLIDA:用于化学基因组学药物发现的GPCR-配体数据库——数据库及工具更新
Nucleic Acids Res. 2008 Jan;36(Database issue):D907-12. doi: 10.1093/nar/gkm948. Epub 2007 Nov 5.
10
Chemogenomic approaches for the exploration of GPCR space.化学生物基因组学方法探索 G 蛋白偶联受体结构域。
Curr Top Med Chem. 2011;11(15):1944-55. doi: 10.2174/156802611796391212.

引用本文的文献

1
Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities.阿片类和肾上腺素能配体与受体的共同进化:共享、互补模块解释功能相互作用的进化并提示新的工程可能性。
Life (Basel). 2021 Nov 10;11(11):1217. doi: 10.3390/life11111217.
2
An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.一种用于分析 GPCR 配体结合的纳米 BRET 示踪剂的综合方法。
Molecules. 2021 May 12;26(10):2857. doi: 10.3390/molecules26102857.
3
Chemogenetic Approach Using Ni(II) Complex-Agonist Conjugates Allows Selective Activation of Class A G-Protein-Coupled Receptors.

本文引用的文献

1
Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.G蛋白偶联受体跨膜束结合口袋的定义及用于药物设计的受体相似性计算。
J Med Chem. 2009 Jul 23;52(14):4429-42. doi: 10.1021/jm900319e.
2
Substructure mining of GPCR ligands reveals activity-class specific functional groups in an unbiased manner.GPCR配体的子结构挖掘以无偏差的方式揭示了活性类别特异性官能团。
J Chem Inf Model. 2009 Feb;49(2):348-60. doi: 10.1021/ci8003896.
3
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
使用镍(II)配合物-激动剂共轭物的化学遗传学方法可实现A类G蛋白偶联受体的选择性激活。
ACS Cent Sci. 2018 Sep 26;4(9):1211-1221. doi: 10.1021/acscentsci.8b00390. Epub 2018 Aug 24.
4
Orphan receptor ligand discovery by pickpocketing pharmacological neighbors.通过“窃取”药理学上的邻近分子来发现孤儿受体配体。
Nat Chem Biol. 2017 Feb;13(2):235-242. doi: 10.1038/nchembio.2266. Epub 2016 Dec 19.
5
CFam: a chemical families database based on iterative selection of functional seeds and seed-directed compound clustering.CFam:一个基于功能种子的迭代选择和种子导向化合物聚类的化学家族数据库。
Nucleic Acids Res. 2015 Jan;43(Database issue):D558-65. doi: 10.1093/nar/gku1212. Epub 2014 Nov 20.
6
Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications.探索中药中的配体-蛋白质网络:当前的数据库、方法及应用
Adv Exp Med Biol. 2015;827:227-57. doi: 10.1007/978-94-017-9245-5_14.
7
PPDMs-a resource for mapping small molecule bioactivities from ChEMBL to Pfam-A protein domains.PPDMs——一种用于将ChEMBL中的小分子生物活性映射到Pfam-A蛋白质结构域的资源。
Bioinformatics. 2015 Mar 1;31(5):776-8. doi: 10.1093/bioinformatics/btu711. Epub 2014 Oct 27.
8
GPCRsort-responding to the next generation sequencing data challenge: prediction of G protein-coupled receptor classes using only structural region lengths.GPCRsort——应对下一代测序数据挑战:仅使用结构区域长度预测G蛋白偶联受体类别
OMICS. 2014 Oct;18(10):636-44. doi: 10.1089/omi.2014.0073. Epub 2014 Aug 18.
9
Biofragments: an approach towards predicting protein function using biologically related fragments and its application to Mycobacterium tuberculosis CYP126.生物片段:一种利用生物相关片段预测蛋白质功能的方法及其在结核分枝杆菌CYP126中的应用
Chembiochem. 2014 Mar 3;15(4):549-55. doi: 10.1002/cbic.201300697.
10
Are phylogenetic trees suitable for chemogenomics analyses of bioactivity data sets: the importance of shared active compounds and choosing a suitable data embedding method, as exemplified on Kinases.系统发生树是否适合于生物活性数据集的化学生物基因组学分析:以激酶为例,共享活性化合物的重要性和选择合适的数据嵌入方法
J Cheminform. 2013 Dec 13;5(1):49. doi: 10.1186/1758-2946-5-49.
与拮抗剂结合的人A2A腺苷受体的2.6埃晶体结构。
Science. 2008 Nov 21;322(5905):1211-7. doi: 10.1126/science.1164772. Epub 2008 Oct 2.
4
Data completeness--the Achilles heel of drug-target networks.数据完整性——药物-靶点网络的致命弱点。
Nat Biotechnol. 2008 Sep;26(9):983-4. doi: 10.1038/nbt0908-983.
5
Dopamine D1 receptor ligands: where are we now and where are we going.多巴胺D1受体配体:我们现在所处的位置以及前进的方向。
Med Res Rev. 2009 Mar;29(2):272-94. doi: 10.1002/med.20130.
6
Structure of a beta1-adrenergic G-protein-coupled receptor.β1-肾上腺素能G蛋白偶联受体的结构
Nature. 2008 Jul 24;454(7203):486-91. doi: 10.1038/nature07101. Epub 2008 Jun 25.
7
Database resources of the National Center for Biotechnology Information.美国国立生物技术信息中心的数据库资源。
Nucleic Acids Res. 2008 Jan;36(Database issue):D13-21. doi: 10.1093/nar/gkm1000. Epub 2007 Nov 27.
8
The universal protein resource (UniProt).通用蛋白质资源(UniProt)。
Nucleic Acids Res. 2008 Jan;36(Database issue):D190-5. doi: 10.1093/nar/gkm895. Epub 2007 Nov 27.
9
Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.化学基因组数据分析:小分子靶点预测与生物指纹图谱的出现
Comb Chem High Throughput Screen. 2007 Sep;10(8):719-31. doi: 10.2174/138620707782507313.
10
GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.GLIDA:用于化学基因组学药物发现的GPCR-配体数据库——数据库及工具更新
Nucleic Acids Res. 2008 Jan;36(Database issue):D907-12. doi: 10.1093/nar/gkm948. Epub 2007 Nov 5.